2025-06-04-Jefferies-Geopark有限公司（GPRK）_初步看法_GPRK的毒丸计划赢得时间_定义价值释放案例是关键_8页_114kb

Summary of Jefferies Latin America Energy Equity Research: Geopark Limited (GPRK) and Pampa Energia SA

Introduction and Key Event:
GeoPark Limited (GPRK) responded to Pampa Energia's acquisition of over 10% of its shares by approving a shareholder rights plan (poison pill), exercisable if any entity exceeds 12% ownership without board approval. Jefferies views this as an overreaction but believes it gives the new CEO time to articulate a value-unlocking case, recommending a Buy rating with a price target of $10.50 (up 47% from $7.15).

Company Descriptions:

• Geopark Limited (GPRK): Founded in 2002, it is a Latin American oil & gas explorer, operator, and consolidator with operations primarily in Chile and Colombia (notably the Llanos 34 block and CPO-5 block).
• Pampa Energia SA: Engages in oil & gas and electricity generation, with significant exposure in Argentina. Jefferies sets a Buy rating with a price target based on NAV under $70/bbl Brent oil price.

Valuation and Risks:

• GPRK Risks:
  • Oil price volatility, currency risk (US$ denominated), political instability in Latin America, environmental damage, production delays, exploration failures.
  • Price target: $10.50, based on NAV.
• Pampa Risks:
  • Energy price fluctuations, currency risk, political/fiscal/environmental risks in Argentina, infrastructure access issues, production performance risks, localized political/economic instability.
  • Price target: Ushered, linked to NAV.

Analyst Certification and Recommendations:

• Jefferies Equity Research assigns a Buy rating to GPRK and Pampa, emphasizing the need for value unlocking under continued dialogue.
• Analysts note limited prior engagement and potential conflicts, urging timely action to avoid entrenchment perceptions.

Key Ratings and Metrics:

• GPRK:
  • Rating: Buy, Price Target: $10.50, Target Change: +47% from prior closing.
  • Current trading range: $5.66 - $11.72, Market Cap: ~$373M.
• Pampa: Buy-rated with no specific price target here, mirroring industry-wide risks.

Conclusion:

Jefferies believes the poison pill is a defensive measure, allowing GeoPark to build a compelling value case while mitigating risks. Both companies face significant geopolitical and market-driven challenges, but analysts maintain a cautiously optimistic outlook under certain assumptions.